Key Players
Competitive Landscape
Four business types compete for the same farm buyers through different product and sales routes. Crop biostimulant specialists and farm-input groups rely on established agricultural channels to reach growers. Seaweed ingredient makers compete through plant-based bioactives, while Bacillus crop-protection firms add fermentation skills. Buyers compare supply consistency, field support, and compatibility with crop programs already used on farms. Every Bacillus metabolite batch must also deliver a repeatable crop response before buyers consider regular use. Reliable lots and practical field support can reduce qualification work before customers place repeat orders.
Recent company actions show how supply capacity and sales access can change without proving Bacillus metabolite demand. In August 2026, Acadian Plant Health and Koppert USA announced separate US sales plans for biostimulant products. In August 2025, Tessenderlo Kerley opened a liquid fertilizer plant in Ohio and expanded domestic crop-input output. Acadian's action changes product access, whereas Tessenderlo's investment changes available production capacity. Bacillus metabolite producers still need dependable supply and farm access before laboratory results can support regular orders.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| August 2026: Acadian Plant Health received a CE Mark for Ready for Stress. | EU customers need harmonized product access and documented performance. | Biostimulant suppliers are formalizing claims under common EU rules. | Registered stress-management products can reach more EU crop programs. |
| July 2025: Algaia joined the first harvest from North Sea Farm 1 as a processing partner. | Bioactive ingredient suppliers need secure biomass and processing routes. | Seaweed extraction is expanding as an alternative biological-input source. | Fermentation suppliers can differentiate on consistency when substitutes rely on variable biomass. |
| February 2025: Olmix and INRAE renewed their research partnership through 2030. | Crop-input developers need field research that links bioactive ingredients with plant and soil performance. | Biostimulant firms are extending joint research beyond single products into longer crop-health programs. | Research partnerships can build crop evidence before standardized biological ingredients enter wider farm use. |
BioAtlantis and SICIT Group sell crop products used for plant-stress management and formulation programs. Certis Biologicals adds Bacillus crop-protection products backed by its fermentation and agricultural biological production capabilities.
Source: Future Market Insights, Bacillus Metabolites Market Report, 2026-2036.
The company group spans crop products and farm sales with both seaweed extraction and Bacillus production capabilities.
Who leads the bacillus metabolites market?
Public records do not identify one company as the share leader in this field. Acadian Plant Health, Olmix Group, and Certis Biologicals compete through different crop-biological product routes.
Which companies have documented qualification or quality approvals?
Acadian Plant Health holds an EU CE Mark for Ready for Stress, while Olmix Group holds PFC 6 certification for Cormin SW. Certis Biologicals also holds crop-protection approvals across its biological product portfolio, giving buyers several documented qualification routes to review.
Which companies provide agricultural bioactive products?
Acadian Plant Health, Olmix Group, BioAtlantis, Hello Nature, and SICIT Group sell crop biostimulants through agricultural product portfolios. Certis Biologicals supplies Bacillus crop-protection products, while Algaia provides seaweed bioactive ingredients for agricultural formulations and product development.
Which companies serve Europe and North America?
Acadian Plant Health and Hello Nature sell crop-biological products across Europe and North America. Tessenderlo Group and Certis Biologicals also serve both regions through established farm-input channels.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Acadian Plant Health | Global crop-biostimulant supplier focused on stress-management formulations. | February 2025: launched its Abiotic Stress Management portfolio for crop resilience and stress tolerance. |
| Olmix Group | Plant-care company supplying seaweed-based and non-microbial biostimulant ingredients. | November 2025: Olmix and Violleau launched the VIO ActiBoost fertilizer range after two years of market testing. |
| BioAtlantis | Irish biostimulant developer with seaweed-based crop-stress and root-zone products. | July 2026: reported first-year progress in the EU-funded VASEACAD crop-stress research project. |
| Hello Nature | Agricultural biosolutions producer with biostimulants, beneficial microbials and organic fertilizers. | June 2025: announced an Italian biostimulant facility expansion intended to double site production capacity. |
| SICIT Group | Protein-hydrolysate and plant-extract biostimulant producer serving agricultural formulators. | November 2025: renewed its EcoVadis Platinum rating and described work on seaweed and moringa extracts. |
| Tessenderlo Group | Diversified agricultural-input group with fertilizer and crop-protection manufacturing. | October 2025: Tessenderlo Kerley acquired Eastman Metam Sodium and Metam Potassium labels in the USA and Canada. |
| Algaia | Seaweed biorefining specialist that supplies substitute bioactive ingredients rather than Bacillus metabolites. | June 2026: Algaia joined LOCALITY agronomic field trials in Poland testing algae-based ingredients under water stress. |
| Certis Biologicals | Biological crop-protection manufacturer with Bacillus fermentation and registered Bacillus products. | March 2025: Certis Biologicals and Certis Belchim announced the first EU authorization of NemaClean. |
Research Methodology
This review includes firms with public records in crop biologicals or Bacillus crop-protection products within the defined scope. The overview does not rank firms by share or sales value because those figures remain part of FMI's private work. Public records must support each named product line or farm business before it enters the comparison. Approvals and certificates can support a capability when they match the product and its role. Company news and public filings give added proof for dated actions and current positions. FMI does not apply one product claim to an entire company without public proof. Private market-share estimates remain outside this overview for the 2026 to 2036 forecast period.
